Key result
Adipose mesenchymal stem cells-derived exosomes administered via subconjunctival and intraocular routes significantly increased retinal micRNA-222 expression and attenuated retinal degeneration in diabetic rabbits.
Why the study?
Do MSCs-derived exosomes improve retina regeneration in a rabbit model of streptozotocin-induced diabetes?
Do MSCs-derived exosomes improve retina regeneration in a rabbit model of streptozotocin-induced diabetes?
Absolute Event Rate: 0.48% vs 0.06%
p-value: p=<0.001
Adipose tissue-derived MSC exosomes demonstrate potential for retinal repair in a rabbit model of diabetic retinopathy, associated with increased expression of micRNA-222.
Hypothesis-generating for MSC exosome-mediated retinal repair in diabetic models; leaves open translation to human diabetic retinopathy.
This study aimed to evaluate the effect of mesenchymal stem cells (MSCs)–derived exosomes in retina regeneration of experimentally induced diabetes mellitus (DM) in a rabbit model. Exosomes are extracellular vesicles that contain many microRNAs (micRNAs), mRNAs, and proteins from their cells of origin. DM was induced by intravenous (IV) injection of streptozotocin in rabbits. MSCs were isolated from adipose tissue of rabbits. Exosomes were extracted from MSCs by ultracentrifugation. Exosomes were injected by different routes (IV, subconjunctival (SC), and intraocular (IO)). Evaluation of the treatment was carried out by histopathological examination of retinal tissues and assessment of micRNA-222 expression level in retinal tissue by real-time polymerase chain reaction. Histologically, by 12 weeks following SC exosomal treatment, the cellular components of the retina were organized in well-defined layers, while IO exosomal injection showed well-defined retinal layers which were obviously similar to layers of the normal retina. However, the retina appeared after IV exosomal injection as irregular ganglionic layer with increased thickness. MicRNA-222 expression level was significantly reduced in diabetic controls when compared to each of healthy controls and other diabetic groups with IV, SC, and IO routes of injected exosomes (0.06 ± 0.02 vs. 0.51 ± 0.07, 0.28 ± 0.08, 0.48 ± 0.06, and 0.42 ± 0.11, respectively). We detected a significant negative correlation between serum glucose and retinal tissue micRNA-222 expression level (r = −0.749, p = 0.001). We can associate the increased expression of micRNA-222 with regenerative changes of retina following administration of MSCs-derived exosomes. The study demonstrates the potency of rabbit adipose tissue–derived MSCs exosomes in retinal repair. So, exosomes are considered as novel therapeutic vectors in MSCs-based therapy through its role in shuttling of many factors including micRNA-222.
No takes yet. Share an insight, caveat, or question.
Safwat et al. (2018) studied Streptozotocin-induced diabetes mellitus with retinal degeneration (n=15). Adipose mesenchymal stem cells-derived exosomes vs. Diabetic control (no exosomes) was evaluated on Retinal tissue micRNA-222 expression level (p=<0.001). Adipose mesenchymal stem cells-derived exosomes administered via subconjunctival and intraocular routes significantly increased retinal micRNA-222 expression and attenuated retinal degeneration in diabetic rabbits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: